A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : PR8 / PR/8/34

[Related PubMed/MEDLINE]
Total Number of Papers: 56
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   PR8  (>> Co-occurring Abbreviation)
Long Form:   PR/8/34
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Generation of highly productive and mammalian nonpathogenic recombinant H9N2 avian influenza viruses by optimization of 3'end promoter and NS genome. AIVs
2019 Mutation of Influenza A Virus PA-X Decreases Pathogenicity in Chicken Embryos and Can Increase the Yield of Reassortant Candidate Vaccine Viruses. HA, NA, NP, ORF, WT
2018 TIMP-1 Promotes the Immune Response in Influenza-Induced Acute Lung Injury. TIMP-1, WT
2017 Effect of the fourth nucleotide at the 3' end of neuraminidase and matrix viral genomic RNA on the pathogenicity of influenza virus A/PR/8/34. IAV, NA, rgPR8, vRNA
2016 Novel strategies for targeting innate immune responses to influenza. ALI, HMGB1, IL, IL-1ra, WT
2015 A Decoy Peptide that Disrupts TIRAP Recruitment to TLRs Is Protective in a Murine Model of Influenza. TIR, TLRs
2014 A promoter mutation in the haemagglutinin segment of influenza A virus generates an effective candidate live attenuated vaccine. EM, HA
2014 Fusion-related host proteins are actively regulated by NA during influenza infection as revealed by quantitative proteomics analysis. MALDI-TOF-TOF MS, MDCK, NAs
2014 Infection of influenza virus neuraminidase-vaccinated mice with homologous influenza virus leads to strong protection against heterologous influenza viruses. HA, NA, NP, pH1N1
10  2014 Specific residues of PB2 and PA influenza virus polymerase subunits confer the ability for RNA polymerase II degradation and virus pathogenicity in mice. RNAPII
11  2013 Comparison of the effectiveness of antibody and cell-mediated immunity against inhaled and instilled influenza virus challenge. Ad, NPA
12  2013 Induction and role of indoleamine 2,3 dioxygenase in mouse models of influenza a virus infection. msLNs
13  2013 NA proteins of influenza A viruses H1N1/2009, H5N1, and H9N2 show differential effects on infection initiation, virus release, and cell-cell fusion. HA, NA
14  2013 Reassortment complements spontaneous mutation in influenza A virus NP and M1 genes to accelerate adaptation to a new host. IAV
15  2012 Development of a murine nose-only inhalation model of influenza: comparison of disease caused by instilled and inhaled A/PR/8/34. MMAD, PFU
16  2012 LGP2 downregulates interferon production during infection with seasonal human influenza A viruses that activate interferon regulatory factor 3. CARDs, IFN, IRF3
17  2012 Major shifts in the spatio-temporal distribution of lung antioxidant enzymes during influenza pneumonia. CAT, GPX3, Gpx8, GSTK1, Prdx6, ROS/RNS, Sod3, Tf
18  2012 Nrf2 protects human alveolar epithelial cells against injury induced by influenza A virus. AdNrf2, AM, ATI-like, ATII, IAV, Nrf2
19  2012 Potential role for alternatively activated macrophages in the secondary bacterial infection during recovery from influenza. AAM, Sp3
20  2011 An alpha-GalCer analogue with branched acyl chain enhances protective immune responses in a nasal influenza vaccine. alpha-GalCer
21  2011 Correlation between sialic acid expression and infection of murine macrophages by different strains of influenza virus. SA
22  2011 Improvement of H5N1 influenza vaccine viruses: influence of internal gene segments of avian and human origin on production and hemagglutinin content. ---
23  2011 The magnitude of the T cell response to a clinically significant dose of influenza virus is regulated by TRAIL. IAV, WT
24  2010 Generation of replication-competent recombinant influenza A viruses carrying a reporter gene harbored in the neuraminidase segment. EGFP, NA, vRNA
25  2010 Influenza viruses differ in ability to infect macrophages and to induce a local inflammatory response following intraperitoneal injection of mice. ---
26  2010 Mixed Lineage Kinase 3 deficiency delays viral clearance in the lung and is associated with diminished influenza-induced cytopathic effect in infected cells. JNK, MLK3
27  2010 MyD88 signaling is indispensable for primary influenza A virus infection but dispensable for secondary infection. RLR, TLR
28  2010 Protective essential oil attenuates influenza virus infection: an in vitro study in MDCK cells. FFA, HA, MDCK
29  2010 Salmonella flagellins are potent adjuvants for intranasally administered whole inactivated influenza vaccine. ---
30  2009 Attenuated strains of influenza A viruses do not induce degradation of RNA polymerase II. hvPR8, RNAP II
31  2009 The NS1 protein of a human influenza virus inhibits type I interferon production and the induction of antiviral responses in primary human dendritic and respiratory epithelial cells. DCs, IFN
32  2008 Targeted deletion of cannabinoid receptors CB1 and CB2 produced enhanced inflammatory responses to influenza A/PR/8/34 in the absence and presence of Delta9 -tetrahydrocannabinol. Delta9 -THC
33  2008 Targeted deletion of cannabinoid receptors CB1 and CB2 produced enhanced inflammatory responses to influenza A/PR/8/34 in the absence and presence of Delta9-tetrahydrocannabinol. ---
34  2007 A single intranasal immunization with inactivated influenza virus and alpha-galactosylceramide induces long-term protective immunity without redirecting antigen to the central nervous system. alpha-GalCer, CTL, NKT
35  2007 Time-dependent airway epithelial and inflammatory cell responses induced by influenza virus A/PR/8/34 in C57BL/6 mice. BALF, dpi, MCM, PCNA, PFU
36  2005 Induction of inducible nitric oxide (NO) synthase mRNA and NO production in macrophages infected with influenza A/PR/8 virus and stimulated with its ether-split product. ESP, NO, TPM
37  2005 Protection against influenza virus infection in BALB/c mice immunized with a single dose of neuraminidase-expressing DNAs by electroporation. HA, NA
38  2001 Immune responses and protection in different strains of aged mice immunized intranasally with an adjuvant-combined influenza vaccine. Ab, AFC, HA, NALT
39  2001 Inhibitory effect of (+)-catechin on the growth of influenza A/PR/8 virus in MDCK cells. ---
40  2000 Involvement of the mannose receptor in infection of macrophages by influenza virus. HANA
41  2000 Polarization of allogeneic T-cell responses by influenza virus-infected dendritic cells. DC, IL-2, NA
42  2000 Protection against influenza virus infection in mice immunized by administration of hemagglutinin-expressing DNAs with electroporation. Ab, HA
43  1999 Enhanced protection against a lethal influenza virus challenge by immunization with both hemagglutinin- and neuraminidase-expressing DNAs. HA, NA
44  1997 Immunogenicity of a contiguous T-B synthetic epitope of the A/PR/8/34 influenza virus. HA
45  1997 Use of oligonucleotide probes for selecting potential high-yielding influenza reassortants. NS
46  1996 Cellular mechanisms involved in protection and recovery from influenza virus infection in immunodeficient mice. ---
47  1994 Formulation of inactivated influenza vaccines for providing effective cross-protection by intranasal vaccination in mice. CTB
48  1993 No recognition of MHC class II+ cells infected with a vaccinia virus encoding influenza type A nucleoprotein by class II-restricted T cells. APC, CTL, ER, NP, Vacc-NP
49  1991 A B cell population that dominates the primary response to influenza virus hemagglutinin does not participate in the memory response. HA
50  1991 Identification of eight determinants in the hemagglutinin molecule of influenza virus A/PR/8/34 (H1N1) which are recognized by class II-restricted T cells from BALB/c mice. HA
51  1991 Influence of a V kappa 8 L chain transgene on endogenous rearrangements and the immune response to the HA(Sb) determinant on influenza virus. HA
52  1990 Replication of H1N1 influenza viruses in cultured mouse embryo brain cells: virus strain and cell differentiation affect synthesis of proteins encoded in RNA segments 7 and 8 and efficiency of mRNA splicing. MEB
53  1989 Effects of cell differentiation on replication of A/WS/33, WSN, and A/PR/8/34 influenza viruses in mouse brain cell cultures: biological and immunological characterization of products. MEB, NA, NP
54  1989 Enhancement of protective antibody responses by cholera toxin B subunit inoculated intranasally with influenza vaccine. H1N1, HI
55  1989 Role of hemagglutinin cleavage and expression of M1 protein in replication of A/WS/33, A/PR/8/34, and WSN influenza viruses in mouse brain. ---
56  1981 Antigenic structure of influenza virus haemagglutinin defined by hybridoma antibodies. HA